NCPI
NIH Cloud PlatformInteroperability Effort
searchclose
YouYube

Study

arrow_backDatasets

NHLBI TOPMed - NHGRI CCDG: AFLMU

phs001543.v1.p1dbGapdbGap FHIR

Description

The Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study contributes to the spectrum of disease by adding carefully characterized patients with atrial fibrillation. Atrial fibrillation, one of the most common human arrhythmias confers major morbidity, mortality and health care cost, and has been demonstrated to be caused and influenced by genetic and -omics factors. Particularly, AFLMU enrolled patients with an early onset of atrial fibrillation to increase the genetic burden on disease pathophysiology. All patients were recruited applying standardized protocols to maintain homogeneity in data and DNA quality.

Summary

PlatformsAnVIL, BDC
Consent CodesHMB-IRB-PUB-COL-NPU-MDS
Focus / DiseasesAtrial Fibrillation
Study DesignCase Set
Data TypesSNP/CNV Genotypes (NGS), WGS
Subjects350